Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer

被引：4
|
作者：
Modi, Shrey [1 ]
Kir, Devika [2 ]
Saluja, Ashok Kumar [1 ,3 ]
机构：
[1] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA
[3] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 04期
关键词：
CA19-9;
D O I：
10.1053/j.gastro.2021.01.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1019 / 1021
页数：3
相关论文
共 50 条
  • [31] ELEVATED CA 19-9 PREDICTS UNRESECTABLE PANCREATIC-CANCER
    LAMBIASE, L
    VOGEL, SB
    FORSMARK, CE
    GASTROENTEROLOGY, 1993, 104 (04) : A418 - A418
  • [32] Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer: Second highest level of CA 19-9 in literature
    Kizilarslanoglu, Muhammet Cemal
    Civelek, Ramazan
    Kilic, Mustafa Kemal
    Kerem, Mustafa
    Gunaydin, Yusuf
    Ulger, Sukran
    JOURNAL OF BUON, 2014, 19 (02): : 583 - 584
  • [33] Predictive value of serum carbohydrate antigen 19-9 (CA19-9) for early mortality in advanced pancreatic cancer
    Junior P.L.S.U.
    Callegaro-Filho D.
    Bugano D.D.G.
    Moura F.
    Maluf F.C.
    Journal of Gastrointestinal Cancer, 2018, 49 (4) : 481 - 486
  • [34] Usefulness of CA 19-9 for pancreatic cancer screening in patients with new-onset diabetes
    Choe, Jung Wan
    Kim, Hyo Jung
    Kim, Jae Seon
    Cha, Jaehyung
    Joo, Moon Kyung
    Lee, Beom Jae
    Park, Jong-Jae
    Bak, Young-Tae
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (03) : 263 - 268
  • [35] New Observations on the Utility of CA 19-9 as a Biomarker in Lewis Negative Patients With Pancreatic Cancer
    Luo, G.
    Yu, X.
    Warshaw, A. L.
    PANCREAS, 2018, 47 (10) : 1407 - 1407
  • [36] CA 19-9 IN THE DIFFERENTIAL-DIAGNOSIS BETWEEN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS
    FARINI, R
    FABRIS, C
    BONVICINI, P
    PICCOLI, A
    DELFAVERO, G
    VENTURINI, R
    PANUCCI, A
    NACCARATO, R
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (04): : 429 - 432
  • [37] UTILITY OF CA 19-9 IN SERUM AND PANCREATIC-SECRETION IN THE DIAGNOSIS OF PANCREATIC-CARCINOMA
    FORSMARK, CE
    ALBERT, CA
    LAMBIASE, L
    VOGEL, SB
    TORRES, GM
    SUMMERLIN, BJ
    TOSKES, PP
    GASTROENTEROLOGY, 1993, 104 (04) : A304 - A304
  • [38] Ca 19-9 can predict early response in patients (PTS) with advanced pancreatic cancer (PC)
    Berardi, Rossana
    Squadroni, Michela
    Scartozzi, Mario
    Silva, Rosa Rita
    Mari, Davide
    Massacesi, Cristian
    Pierantoni, Chiara
    Cascinu, Stefano
    ANNALS OF ONCOLOGY, 2006, 17 : 323 - 323
  • [39] Limited Value of CA 19-9 in Predicting Early Treatment Failure in Patients with Advanced Pancreatic Cancer
    Vormittag, Laurenz
    Gleiss, Andreas
    Scheithauer, Werner
    Lang, Fritz
    Laengle, Friedrich
    Kornek, Gabriela V.
    ONCOLOGY, 2009, 77 (02) : 140 - 146
  • [40] CA 19-9 LEVEL AS INDICATOR OF EARLY DISTANT METASTASIS AND THERAPEUTIC SELECTION IN RESECTED PANCREATIC CANCER
    Kim, Tae Hyun
    Han, Sung-Sik
    Park, Sang-Jae
    Lee, Woo Jin
    Woo, Sang Myung
    Yoo, Tae
    Moon, Sung Ho
    Kim, Seong Hoon
    Hong, Eun Kyung
    Kim, Dae Yong
    Park, Joong-Won
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : E743 - E748
12345